Rival drugmakers launch joint trial of medicines for COVID-19

日本 ニュース ニュース

Rival drugmakers launch joint trial of medicines for COVID-19
日本 最新ニュース,日本 見出し
  • 📰 Reuters
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Rival drugmakers AbbVie Inc , Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.

) on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.

The COVID-19 pandemic is an “all hands on deck moment,” David Reese, Amgen’s research and development chief told Reuters. “We wanted a trial to be able to quickly sift through multiple agents and prioritize.” The first segment will test whether Amgen’s psoriasis drug Otezla, Takeda’s anti-inflammatory Firazyr and AbbVie’s cenicriviroc, which has been tried in patients with HIV, will help with the overactive, and potentially damaging, immune response that sometimes happens in patients with severe COVID-19.

“We could have some results in as early as six weeks,” she said, adding that additional drugs will soon be added to the roster.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

Reuters /  🏆 2. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

'Lunatic hiding in plain sight': The bitter tale of a woman-hating lawyer who killed a rival and a judge's son'Lunatic hiding in plain sight': The bitter tale of a woman-hating lawyer who killed a rival and a judge's sonBefore his killing spree, 'anti-feminist' attorney Roy Den Hollander blamed everyone from his mom to his ex-wife for a miserable life.
続きを読む »

What to watch today: Dow to rise as Wall Street monitors D.C. coronavirus relief talksWhat to watch today: Dow to rise as Wall Street monitors D.C. coronavirus relief talksStock futures were higher as Congress negotiates the next relief package and Eli Lilly announces late-stage trial for Covid-19 drug.
続きを読む »

College move-in, fined to resign, testing goals: News from around our 50 statesCollege move-in, fined to resign, testing goals: News from around our 50 statesDay One of dorm life looks a lot different during a pandemic.
続きを読む »

Boosting Immunity Is A Dangerous MythBoosting Immunity Is A Dangerous Myth'It’s best to shore up the bouncers while we can. And by that, I don’t mean 'strengthen' or 'boost' your immune system. Instead, it needs to be balanced and optimized, so it functions as it’s designed to.'
続きを読む »

Boosting Immunity Is A Dangerous MythBoosting Immunity Is A Dangerous Myth'It’s best to shore up the bouncers while we can. And by that, I don’t mean 'strengthen' or 'boost' your immune system. Instead, it needs to be balanced and optimized, so it functions as it’s designed to.'
続きを読む »



Render Time: 2025-03-09 18:27:56